UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

The Prostate, 1999-01, Vol.38 (1), p.73-78

1999

Volltextzugriff (PDF)

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

The Prostate, 1999-04, Vol.39 (1), p.54-59

1999

Volltextzugriff (PDF)

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

The Prostate, 1998-06, Vol.36 (1), p.39-44

1998

Volltextzugriff (PDF)

Follow-up evaluation of a phase II prostate cancer vaccine trial

The Prostate, 1999-07, Vol.40 (2), p.125-129

1999

Volltextzugriff (PDF)

Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients

The Prostate, 2000-04, Vol.43 (1), p.59-62

2000

Volltextzugriff (PDF)

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

The Prostate, 1997-09, Vol.32 (4), p.272-278

1997

Volltextzugriff (PDF)

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

The Prostate, 1999-06, Vol.39 (4), p.291-297

1999

Volltextzugriff (PDF)

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

The Prostate, 1998-05, Vol.35 (2), p.144-151

1998

Volltextzugriff (PDF)

Dendritic cell-based immunotherapy for prostate cancer

CA: a cancer journal for clinicians, 1999-03, Vol.49 (2), p.117-128

1999

Volltextzugriff (PDF)

Dendritic cell-based immunotherapy of prostate cancer

Critical reviews in immunology, 1998, Vol.18 (1-2), p.109-119

1998

Volltextzugriff (PDF)

Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients

The Prostate, 2000-01, Vol.42 (1), p.67-72

2000

Volltextzugriff (PDF)

Progress in active-specific immunotherapy of brain malignancies

Expert opinion on investigational drugs, 2000-09, Vol.9 (9), p.2093-2101

2000

Volltextzugriff (PDF)

Measurement of prostate-specific membrane antigen in the serum with a new antibody

The Prostate, 1996-04, Vol.28 (4), p.266-271

1996

Volltextzugriff (PDF)

VACCINE THERAPY FOR PROSTATE CANCER

Urologic clinics of North America, 1999-05, Vol.26 (2), p.365-374

1999

Volltextzugriff (PDF)

Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex : a model for peptide-mediated tumor rejection

Cancer research (Chicago, Ill.), 1994, Vol.54 (1), p.204-208

1994

Volltextzugriff (PDF)

Development of dendritic-cell based prostate cancer vaccine

Immunology letters, 2000-09, Vol.74 (1), p.87-93

2000

Volltextzugriff (PDF)

Sequence diversity of T cell receptor α chain transcripts from BALB/c thymus

Molecular immunology, 1992-12, Vol.29 (12), p.1447-1455

1992

Volltextzugriff (PDF)

Progress in active specific immunotherapy of prostate cancer

Seminars in surgical oncology, 2000-01, Vol.18 (1), p.80-87

2000

Volltextzugriff (PDF)

Sequence restrictions in T cell receptor β-chains that have specificity for a self-peptide/Ld complex

Molecular immunology, 1994-07, Vol.31 (10), p.705-711

1994

Volltextzugriff (PDF)

Wellness Programs

Journal of the American College of Radiology, 2012-12, Vol.9 (12), p.894-899

2012

Volltextzugriff (PDF)

Vaccine therapy for prostate cancer : Hormone refractory prostate cancer

Urologic clinics of North America, 1999, Vol.26 (2)

1999

Volltextzugriff (PDF)

Dendritic cell-based immunotherapy for prostate cancer

CA: a cancer journal for clinicians, 1999-03, Vol.49 (2), p.65-65

1999

Volltextzugriff (PDF)

Sequence restrictions in T cell receptor beta -chains that have specificity for a self-peptide/L super(d) complex

Molecular immunology, 1994-01, Vol.31 (10), p.705-711

1994

Volltextzugriff (PDF)

Harvesting correlations in Schwarzschild and collapsing shell spacetimes

The journal of high energy physics, 2020-08, Vol.2020 (8), p.1-40, Article 155

2020

Volltextzugriff (PDF)

Entanglement harvesting with moving mirrors

The journal of high energy physics, 2019-06, Vol.2019 (6), p.1-20, Article 21

2019

Volltextzugriff (PDF)

1 – 25 von 412

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(295)
Mit Volltextzugriff
(374)

Publikationsform

Sprache

Englisch
(411)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

Follow-up evaluation of a phase II prostate cancer vaccine trial

Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

Dendritic cell-based immunotherapy for prostate cancer

Dendritic cell-based immunotherapy of prostate cancer

Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients

Progress in active-specific immunotherapy of brain malignancies

Measurement of prostate-specific membrane antigen in the serum with a new antibody

VACCINE THERAPY FOR PROSTATE CANCER

Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex : a model for peptide-mediated tumor rejection

Development of dendritic-cell based prostate cancer vaccine

Sequence diversity of T cell receptor α chain transcripts from BALB/c thymus

Progress in active specific immunotherapy of prostate cancer

Sequence restrictions in T cell receptor β-chains that have specificity for a self-peptide/Ld complex

Wellness Programs

Vaccine therapy for prostate cancer : Hormone refractory prostate cancer

Dendritic cell-based immunotherapy for prostate cancer

Sequence restrictions in T cell receptor beta -chains that have specificity for a self-peptide/L super(d) complex

Harvesting correlations in Schwarzschild and collapsing shell spacetimes

Entanglement harvesting with moving mirrors

Suchergebnisse filtern